Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan ter Meulen

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|July 27, 2016
An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge ModelsReed F Johnson, Drishya Kurup, Katie R Hagen, et al.
Journal of Clinical Microbiology|December 31, 2010
Current molecular epidemiology of Lassa virus in NigeriaDeborah U Ehichioya, Meike Hass, Beate Becker-Ziaja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaShailender Bhatia, Natalie J Miller, Hailing Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
Emerging Infectious Diseases|March 1, 2007
Mastomys natalensis and Lassa fever, West AfricaEmilie Lecompte, Elisabeth Fichet-Calvet, Stéphane Daffis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapyJared M Odegard, Brenna Kelley-Clarke, Semih U Tareen, et al.
Plos One|December 17, 2008
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cellsMark Throsby, Edward van den Brink, Mandy Jongeneelen, et al.
Lancet (London, England)|June 29, 2004
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferretsJan ter Meulen, Alexander B H Bakker, Edward N van den Brink, et al.
Plos Pathogens|November 21, 2015
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionRami Sommerstein, Lukas Flatz, Melissa M Remy, et al.
Cell Reports|January 10, 2019
Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus EnvelopeXishan Lu, Haixia Xiao, Shihua Li, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|July 27, 2016
An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge ModelsReed F Johnson, Drishya Kurup, Katie R Hagen, et al.
Journal of Clinical Microbiology|December 31, 2010
Current molecular epidemiology of Lassa virus in NigeriaDeborah U Ehichioya, Meike Hass, Beate Becker-Ziaja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaShailender Bhatia, Natalie J Miller, Hailing Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
Emerging Infectious Diseases|March 1, 2007
Mastomys natalensis and Lassa fever, West AfricaEmilie Lecompte, Elisabeth Fichet-Calvet, Stéphane Daffis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapyJared M Odegard, Brenna Kelley-Clarke, Semih U Tareen, et al.
Plos One|December 17, 2008
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cellsMark Throsby, Edward van den Brink, Mandy Jongeneelen, et al.
Lancet (London, England)|June 29, 2004
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferretsJan ter Meulen, Alexander B H Bakker, Edward N van den Brink, et al.
Plos Pathogens|November 21, 2015
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionRami Sommerstein, Lukas Flatz, Melissa M Remy, et al.
Cell Reports|January 10, 2019
Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus EnvelopeXishan Lu, Haixia Xiao, Shihua Li, et al.
Pageof 6